|
USP34 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.81147999999132E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.980440E-04 |
| Normal-vs-Stage2 |
3.622400E-04 |
| Normal-vs-Stage3 |
3.29009999999741E-06 |
| Normal-vs-Stage4 |
1.202840E-04 |
| Stage1-vs-Stage2 |
2.221200E-01 |
| Stage1-vs-Stage3 |
1.640580E-01 |
| Stage1-vs-Stage4 |
5.061400E-01 |
| Stage2-vs-Stage3 |
8.305000E-01 |
| Stage2-vs-Stage4 |
5.646800E-01 |
| Stage3-vs-Stage4 |
6.143800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.10140000003845E-06 |
| Normal-vs-AfricanAmerican |
1.794790E-01 |
| Normal-vs-Asian |
1.113660E-02 |
| Caucasian-vs-AfricanAmerican |
8.878000E-02 |
| Caucasian-vs-Asian |
4.883800E-02 |
| AfricanAmerican-vs-Asian |
6.347600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.176040E-04 |
| Normal-vs-Female |
2.17769999999451E-05 |
| Male-vs-Female |
7.670600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.187100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.185720E-04 |
| Normal-vs-Age(61-80Yrs) |
1.53860999999589E-05 |
| Normal-vs-Age(81-100Yrs) |
8.402900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.184800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.667640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.393000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.843400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.217400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.842600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.364380E-01 |
| Classical-VS-Follicular |
1.220550E-03 |
| Classical-VS-Other |
7.535400E-01 |
| Classical-VS-Normal |
9.411800E-04 |
| Tall-VS-Follicular |
2.800200E-01 |
| Tall-VS-Other |
6.376600E-01 |
| Tall-VS-Normal |
5.760000E-04 |
| Follicular-VS-Other |
4.248800E-01 |
| Follicular-VS-Normal |
8.00789999977347E-07 |
| Other-VS-Normal |
1.163360E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.33299999991199E-07 |
| Normal-vs-N1 |
2.47279999999739E-05 |
| N0-vs-N1 |
9.747600E-01 |
|
|
